Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trial.
Candoni A, Papayannidis C, Martinelli G, Simeone E, Gottardi M, Iacobucci I, Gherlinzoni F, Visani G, Baccarani M, Fanin R. Candoni A, et al. Among authors: fanin r. Am J Hematol. 2018 May;93(5):655-663. doi: 10.1002/ajh.25057. Epub 2018 Mar 2. Am J Hematol. 2018. PMID: 29396857 Free article. Clinical Trial.
Pregnancy and abortion in women with essential thrombocythemia.
Candoni A, Fanin R, Michelutti T, Russo D, Michelutti A. Candoni A, et al. Among authors: fanin r. Am J Hematol. 2002 Mar;69(3):233-4. doi: 10.1002/ajh.10068. Am J Hematol. 2002. PMID: 11891817 Free article. No abstract available.
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A, Baccarani M, Fanin R, Ferraccioli G. Zaja F, et al. Among authors: fanin r. Blood. 2003 May 15;101(10):3827-34. doi: 10.1182/blood-2002-09-2856. Epub 2003 Jan 30. Blood. 2003. PMID: 12560225 Free article. Clinical Trial.
Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization.
Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A, Cellini C, Curti A, Gugliotta L, Visani G, Fanin R, Baccarani M. Lemoli RM, et al. Among authors: fanin r. Blood. 2003 Sep 1;102(5):1595-600. doi: 10.1182/blood-2003-02-0440. Epub 2003 Apr 24. Blood. 2003. PMID: 12714501 Free article. Clinical Trial.
401 results